107

News

US authorities approve Danish cancer drug

TheCopenhagenPost
November 17th, 2015


This article is more than 9 years old.

Biotech company Genmab looking forward to a big year

A banner year ahead for Genmab (photo: Genmab)

The Danish biotech company Genmab, which specialises in developing anti-cancer drugs, has received approval for its drug Darzalex by the US Food and Drug Administration (FDA).

The company confirmed the approval in a stock exchange announcement on Monday evening.

Darzalex is a bone cancer drug that primarily aids patients who have already gone through several unsuccessful treatments for multiple melanoma, an incurable form of blood cancer that originates in the bone marrow and is the third most common form of blood cancer in the US.

Financial boon
Darzalex was initially approved only for patients who have gone through at least three previous treatment attempts. But Genmab and its partner Janssen are now working to have it approved as a first line treatment.

The approval raises Genmab’s financial expectations for fiscal 2015.

The company, which is listed on the Copenhagen Stock Exchange, is now anticipating sales of between 1.02 to 1.1 billion kroner – about 300 million kroner more than previously forecast.

Its operating profit is expected to be between 625 and 700 million kroner, up from the previously forecast 325 to 400 million kroner.

When the markets closed yesterday, Genmab’s stock price stood at 744 kroner.


Share

Most popular

Subscribe to our newsletter

Sign up to receive The Daily Post

















Latest Podcast

A survey carried out by Megafon for TV2 has found that 71 percent of parents have handed over children to daycare in spite of them being sick.

Moreover, 21 percent of those surveyed admitted to medicating their kids with paracetamol, such as Panodil, before sending them to school.

The FOLA parents’ organisation is shocked by the findings.

“I think it is absolutely crazy. It simply cannot be that a child goes to school sick and plays with lots of other children. Then we are faced with the fact that they will infect the whole institution,” said FOLA chair Signe Nielsen.

Pill pushers
At the Børnehuset daycare institution in Silkeborg a meeting was called where parents were implored not to bring their sick children to school.

At Børnehuset there are fears that parents prefer to pack their kids off with a pill without informing teachers.

“We occasionally have children who that they have had a pill for breakfast,” said headteacher Susanne Bødker. “You might think that it is a Panodil more than a vitamin pill, if it is a child who has just been sick, for example.”

Parents sick and tired
Parents, when confronted, often cite pressure at work as a reason for not being able to stay at home with their children.

Many declare that they simply cannot take another day off, as they are afraid of being fired.

Allan Randrup Thomsen, a professor of virology at KU, has heavily criticised the parents’ actions, describing the current situation as a “vicious circle”.

“It promotes the spread of viruses, and it adds momentum to a cycle where parents are pressured by high levels of sick-leave. If they then choose to send the children to daycare while they are still recovering, they keep the epidemic going in daycares, and this in turn puts a greater burden on the parents.”